Dhakarwal P, Medhi M, Muthuchelvan D, Chaudhuri P, Viswas K, Patel B
Braz J Microbiol. 2025; 56(1):651-663.
PMID: 39832111
PMC: 11885734.
DOI: 10.1007/s42770-024-01610-9.
Rahmanzad F, Amini Najafi F, Bahonar A, Parvandar Asadollahi K
Arch Razi Inst. 2024; 79(2):437-444.
PMID: 39463717
PMC: 11512190.
DOI: 10.32592/ARI.2024.79.2.437.
Blacksell S, Dhawan S, Kusumoto M, Le K, Summermatter K, OKeefe J
Appl Biosaf. 2023; 28(3):135-151.
PMID: 37736423
PMC: 10510692.
DOI: 10.1089/apb.2022.0038.
Alger K, Ip H, Hall J, Nashold S, Richgels K, Smith C
Appl Biosaf. 2022; 24(4):189-199.
PMID: 36032057
PMC: 9134477.
DOI: 10.1177/1535676019888920.
Bortolami A, Mazzetto E, Kangethe R, Wijewardana V, Barbato M, Porfiri L
Front Vet Sci. 2022; 9:916108.
PMID: 35898545
PMC: 9309530.
DOI: 10.3389/fvets.2022.916108.
Preparation of an Inactivated Peste des Petits Ruminants Vaccine and Its Comparative Immunogenicity Evaluation in an Animal Model.
Akbarian M, Keyvanfar H, Lotfi M, Azimi Dezfuli S, Varshovi H
Arch Razi Inst. 2022; 76(4):731-739.
PMID: 35096309
PMC: 8790992.
DOI: 10.22092/ari.2020.351398.1523.
Protective efficacy of inactivated Newcastle disease virus vaccines prepared in two different oil-based adjuvants.
Aljumaili O, Bello M, Yeap S, Omar A, Ideris A
Onderstepoort J Vet Res. 2020; 87(1):e1-e7.
PMID: 33054260
PMC: 7565102.
DOI: 10.4102/ojvr.v87i1.1865.
Efficacy of inactivated velogenic Newcastle disease virus genotype VII vaccine in broiler chickens.
Fawzy M, Ali R, Elfeil W, Saleh A, El-Tarabilli M
Vet Res Forum. 2020; 11(2):113-120.
PMID: 32782739
PMC: 7413011.
DOI: 10.30466/vrf.2019.95311.2295.
Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
Herrera-Rodriguez J, Signorazzi A, Holtrop M, De Vries-Idema J, Huckriede A
Vaccine. 2019; 37(12):1630-1637.
PMID: 30765167
PMC: 7115651.
DOI: 10.1016/j.vaccine.2019.01.086.
Prime-boost vaccination strategy against avian influenza and Newcastle disease viruses reduces shedding of the challenge viruses.
Ismail N, El-Deeb A, Emara M, Tawfik H, Wanis N, Hussein H
Virusdisease. 2018; 29(3):324-332.
PMID: 30159367
PMC: 6111958.
DOI: 10.1007/s13337-018-0463-3.
Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
Kumar S, Chelvaretnam S, Tan Y, Prabakaran M
Viruses. 2018; 10(1).
PMID: 29295514
PMC: 5795415.
DOI: 10.3390/v10010002.
Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
Santos J, Obadan A, Cardenas Garcia S, Carnaccini S, Kapczynski D, Pantin-Jackwood M
Vaccine. 2017; 35(42):5637-5643.
PMID: 28886943
PMC: 5659307.
DOI: 10.1016/j.vaccine.2017.08.059.
Seroconversion and immunogenicity evaluation of seasonal influenza vaccine in mice model.
Bharmoria A, Vaish V, Mani K
Virusdisease. 2017; 27(3):260-265.
PMID: 28466037
PMC: 5394711.
DOI: 10.1007/s13337-016-0336-6.
Age-dependent immune responses and immune protection after avian coronavirus vaccination.
van Ginkel F, Padgett J, Martinez-Romero G, Miller M, Joiner K, Gulley S
Vaccine. 2015; 33(23):2655-61.
PMID: 25910920
PMC: 7115535.
DOI: 10.1016/j.vaccine.2015.04.026.
Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.
Prabakaran M, Leyrer S, He F, Auer S, Kumar S, Kindsmueller K
PLoS One. 2014; 9(9):e107316.
PMID: 25229722
PMC: 4167863.
DOI: 10.1371/journal.pone.0107316.
Effect of formaldehyde inactivation on poliovirus.
Wilton T, Dunn G, Eastwood D, Minor P, Martin J
J Virol. 2014; 88(20):11955-64.
PMID: 25100844
PMC: 4178759.
DOI: 10.1128/JVI.01809-14.
Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection.
Kapczynski D, Pantin-Jackwood M, Guzman S, Ricardez Y, Spackman E, Bertran K
J Virol. 2013; 87(16):9086-96.
PMID: 23760232
PMC: 3754080.
DOI: 10.1128/JVI.00666-13.
Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice.
Kim E, Lee J, Pascua P, Song M, Baek Y, Kwon H
Virol J. 2013; 10:104.
PMID: 23551908
PMC: 3621599.
DOI: 10.1186/1743-422X-10-104.
Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.
Prabakaran M, Meng T, He F, Yunrui T, Qiang J, Pin Lin R
Clin Vaccine Immunol. 2011; 18(9):1582-5.
PMID: 21752948
PMC: 3165240.
DOI: 10.1128/CVI.05114-11.
Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.
Prabakaran M, He F, Meng T, Madhan S, Yunrui T, Jia Q
J Virol. 2010; 84(22):11822-30.
PMID: 20844051
PMC: 2977865.
DOI: 10.1128/JVI.00891-10.